Evgenia Salta

3.8k total citations · 2 hit papers
27 papers, 2.0k citations indexed

About

Evgenia Salta is a scholar working on Molecular Biology, Cancer Research and Developmental Neuroscience. According to data from OpenAlex, Evgenia Salta has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Developmental Neuroscience. Recurrent topics in Evgenia Salta's work include MicroRNA in disease regulation (13 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Circular RNAs in diseases (6 papers). Evgenia Salta is often cited by papers focused on MicroRNA in disease regulation (13 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Circular RNAs in diseases (6 papers). Evgenia Salta collaborates with scholars based in Belgium, Netherlands and United Kingdom. Evgenia Salta's co-authors include Bart De Strooper, Annerieke Sierksma, Elke Vanden Eynden, Paul J. Lucassen, Pierre Lau, Carlos P. Fitzsimons, Carlo Sala Frigerio, Mark Fiers, Hannah Walgrave and Koen Bossers and has published in prestigious journals such as Science, Neuron and The EMBO Journal.

In The Last Decade

Evgenia Salta

26 papers receiving 2.0k citations

Hit Papers

MEG3 activates necroptosis in human neuron xenografts mod... 2023 2026 2024 2025 2023 2023 40 80 120

Peers

Evgenia Salta
Evgenia Salta
Citations per year, relative to Evgenia Salta Evgenia Salta (= 1×) peers Sophie Mouillet‐Richard

Countries citing papers authored by Evgenia Salta

Since Specialization
Citations

This map shows the geographic impact of Evgenia Salta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgenia Salta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgenia Salta more than expected).

Fields of papers citing papers by Evgenia Salta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgenia Salta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgenia Salta. The network helps show where Evgenia Salta may publish in the future.

Co-authorship network of co-authors of Evgenia Salta

This figure shows the co-authorship network connecting the top 25 collaborators of Evgenia Salta. A scholar is included among the top collaborators of Evgenia Salta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgenia Salta. Evgenia Salta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Penning, Amber, et al.. (2024). NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer’s disease. Scientific Reports. 14(1). 21163–21163. 3 indexed citations
2.
Balusu, Sriram, Katrien Horré, Nicola Thrupp, et al.. (2023). MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease. Science. 381(6663). 1176–1182. 128 indexed citations breakdown →
3.
Walgrave, Hannah, Amber Penning, Kristofer Davie, et al.. (2023). microRNA-132 regulates gene expression programs involved in microglial homeostasis. iScience. 26(6). 106829–106829. 28 indexed citations
4.
Salta, Evgenia, Orly Lazarov, Carlos P. Fitzsimons, et al.. (2023). Adult hippocampal neurogenesis in Alzheimer’s disease: A roadmap to clinical relevance. Cell stem cell. 30(2). 120–136. 80 indexed citations breakdown →
5.
Verhaagen, Joost, et al.. (2023). Synergetic microRNA delivery for therapeutic targeting in Alzheimer’s disease. Alzheimer s & Dementia. 19(S13). 1 indexed citations
6.
Bryois, Julien, et al.. (2023). Mapping human adult hippocampal neurogenesis with single-cell transcriptomics: Reconciling controversy or fueling the debate?. Neuron. 111(11). 1714–1731.e3. 47 indexed citations
7.
Maruszak, Aleksandra, Edina Silajdžić, Hyun-Ah Lee, et al.. (2022). Predicting progression to Alzheimer’s disease with human hippocampal progenitors exposed to serum. Brain. 146(5). 2045–2058. 19 indexed citations
8.
Zhang, Lin, Paul J. Lucassen, Evgenia Salta, Peter Verhaert, & Dick F. Swaab. (2021). Hippocampal neuropathology in suicide: Gaps in our knowledge and opportunities for a breakthrough. Neuroscience & Biobehavioral Reviews. 132. 542–552. 13 indexed citations
9.
Walgrave, Hannah, Lujia Zhou, Bart De Strooper, & Evgenia Salta. (2021). The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives. Molecular Neurodegeneration. 16(1). 76–76. 85 indexed citations
10.
Sierksma, Annerieke, Ashley Lu, Renzo Mancuso, et al.. (2020). Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology. EMBO Molecular Medicine. 12(3). e10606–e10606. 190 indexed citations
11.
Samaridou, Eleni, et al.. (2019). Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases. Biomaterials. 230. 119657–119657. 76 indexed citations
12.
Lievens, Sam, Luís F. Ribeiro, Katrien Horré, et al.. (2019). Nuclear import of the DSCAM ‐cytoplasmic domain drives signaling capable of inhibiting synapse formation. The EMBO Journal. 38(6). 38 indexed citations
13.
Lucassen, Paul J., Carlos P. Fitzsimons, Evgenia Salta, & Mirjana Maletić‐Savatić. (2019). Adult neurogenesis, human after all (again): Classic, optimized, and future approaches. Behavioural Brain Research. 381. 112458–112458. 67 indexed citations
14.
Sierksma, Annerieke, Ashley Lu, Evgenia Salta, et al.. (2018). Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration. 13(1). 54–54. 94 indexed citations
15.
Salta, Evgenia & Bart De Strooper. (2017). Noncoding RNAs in neurodegeneration. Nature reviews. Neuroscience. 18(10). 627–640. 119 indexed citations
16.
Salta, Evgenia, Annerieke Sierksma, Elke Vanden Eynden, & Bart De Strooper. (2016). miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain. EMBO Molecular Medicine. 8(9). 1005–1018. 128 indexed citations
17.
Lau, Pierre, Koen Bossers, Rekin’s Janky, et al.. (2013). Alteration of the micro RNA network during the progression of Alzheimer's disease. EMBO Molecular Medicine. 5(10). 1613–1634. 377 indexed citations
18.
Koukouli, Fani, Ioannis Paspaltsis, Evgenia Salta, et al.. (2012). Inhibition of PrPScformation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives. Prion. 6(5). 470–476. 6 indexed citations
19.
Salta, Evgenia & Bart De Strooper. (2012). Non-coding RNAs with essential roles in neurodegenerative disorders. The Lancet Neurology. 11(2). 189–200. 204 indexed citations
20.
Málaga‐Trillo, Edward, Evgenia Salta, António Figueras, Cynthia H. Panagiotidis, & Theodoros Sklaviadis. (2010). Fish models in prion biology: Underwater issues. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(3). 402–414. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026